Logo Image
|Articles|March 1, 2002

Pharmaceutical Technology

  • Pharmaceutical Technology-03-02-2002
  • Volume 26
  • Issue 3

Drug Safety Concerns Shape Manufacturing Policy

Author(s)Jill Wechsler

FDA wants manufacturers to revise product labeling and packaging and step up adverse-event monitoring to reduce risky product use.
External Link - article-12151.pdf

Articles in this issue

over 24 years ago

Outsourcing Outlook

over 24 years ago

Developing Custom Adhesive Systems for Transdermal Drug Delivery

over 24 years ago

Overview of Technologies Supporting Security Requirements in 21 CFR Part 11, Part II

over 24 years ago

PDA Task Force Issues Guidelines to Aid Isolator Users

over 24 years ago

Recent Advances in Semisolid Dosage Forms for Dermatological Application

over 24 years ago

Production Information Mangement

over 24 years ago

Functionality Testing of a Multifunctional Directly Compressible Adjuvant Containing Lactose, Polyvinylpyrrolidone, and Croscarmellose Sodium

over 24 years ago

Public CROs Craft New Strategies to Achieve Financial and Strategic Objectives

over 24 years ago

Validation Changes to the USP Assay Method for Ibuprofen Tablets

over 24 years ago

Systematic Troubleshooting for LC/MS/MS

Related to this article

View more